Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2004
02/11/2004CN1137997C Cold-inducible promoter sequences
02/11/2004CN1137898C Analogs of parathyroid hormone
02/11/2004CN1137897C Process for preparing recombined human thrombopoietin preparation
02/11/2004CN1137896C Vaccine for hoof-and-mouth disease and preparing method thereof
02/11/2004CN1137779C Method for preparing 3,4-dichlorophenylnitrile by using ammonia oxidation process and its special purpose catalyst
02/11/2004CN1137726C Method of prolonged suppression of humoral immunity
02/11/2004CN1137722C Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens
02/11/2004CN1137688C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
02/10/2004US6689940 Nucleic acid encoding the arabidopsis ELF3 protein and a method of using it to alter photoperiod in plants
02/10/2004US6689939 GTP binding stress-related proteins and methods of use in plants
02/10/2004US6689938 Administering an antagonist of melanocortin stimulating hormone (msh) biological activity.
02/10/2004US6689937 Transgenic mouse model of basal cell carcinoma
02/10/2004US6689879 Nucleotide sequences coding nvelope protein for use in the prevention of viral diseases
02/10/2004US6689878 Vaccine for preventing staphylococcus aureus infection
02/10/2004US6689877 Administering a therapeutic amount of nebr1 antiretroviral transcriptional factor to hiv infected cells in patient
02/10/2004US6689876 Cloning and sequencing of allergens of dermatophagoides
02/10/2004US6689873 Nucleic acid encoding rat agouti related protein
02/10/2004US6689871 Process for production diphtheria toxin
02/10/2004US6689870 Protein macromolecular dyes
02/10/2004US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same
02/10/2004US6689868 Isolated antibody which selectively binds to isolated cd2bp1 protein having specified amino acid sequence
02/10/2004US6689867 Placenta derived apoptotic factor
02/10/2004US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity
02/10/2004US6689865 Nucleic acid molecules encoding DRT111 and uses thereof
02/10/2004US6689864 Isolated polypeptide comprising cyclin dependent kinase 4 inhibitor or biologically active fragment thereof, encoded by dna molecule consisting of specified sequence
02/10/2004US6689813 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects
02/10/2004US6689758 Treating wounds; using an early growth response-1 transcription factor polypeptide or fragment
02/10/2004US6689753 Alzheimer inhibitor peptide ia beta 5 (amino acid sequence 1leu-pro-phe-phe-asp) analog
02/10/2004US6689752 Amino-terminal modifying groups include cyclic, heterocyclic, polycyclic and branched alkyls, and carboxy-terminal modifying groups include an amide, an alkyl amide, an aryl amide or a hydroxy; treating alzheimer's disease
02/10/2004US6689751 Peptide comprising amino acid sequence 15 or 83 with alanine or alpha-aminoisobutyrate substitution
02/10/2004US6689750 Bactericide compositions prepared and obtained from microccus varians
02/10/2004US6689749 Voltage gated potassium channel blockers; interleukin-2 inhibitors; polypeptide having up to four cysteine based disulfide bonds
02/10/2004US6689747 Use of insulin for the treatment of cartilagenous disorders
02/10/2004US6689743 Bacillus thuringiensis isolates and toxins
02/10/2004US6689742 NY-ESO-1 peptide derivatives, and uses thereof
02/10/2004US6689611 Modified Streptomyces host cells for increased avermectin production and methods of making the same
02/10/2004US6689610 Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
02/10/2004US6689607 Antibody for use in the treatment of aberrant cell proliferation and differentiation defects
02/10/2004US6689605 Controlling immune response to specific antigens
02/10/2004US6689598 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
02/10/2004US6689586 Nucleotide sequences which code for the CcpA2 gene
02/10/2004US6689585 GABA-B2 receptor
02/10/2004US6689584 Transcriptional regulatory factor
02/10/2004US6689583 Chromatin regulator genes
02/10/2004US6689582 Polynucleotide molecules encoding proteins having proteinase inhibitor activity
02/10/2004US6689581 Potassium channel interactors and uses therefor
02/10/2004US6689580 Growth factor
02/10/2004US6689579 That stimulates b lymphocyte proliferation, differentiation, or survival; novel cytokine expressed by neutrophils; vectors, host cells
02/10/2004US6689566 Methods, kits, and antibodies for detecting parathyroid hormone
02/10/2004US6689562 Mammalian IAP gene family, primers, probes and detection methods
02/10/2004US6689561 Isolated cdk4i gene (cdk4i=cyclin-dependent kinase 4 inhibitor), in which deletions or polymorphisms have been shown to cause susceptibility to certain cancers; detecting deletions or polymorphisms; kits, diagnosis
02/10/2004US6689560 Inhibiting raf expression by expressing an antisense raf gene; inhibiting a cellular transformation phenotype induced by an oncogene
02/10/2004US6689559 Efficient hepatitis C virus replicon and its use in identifying antiviral compounds
02/10/2004US6689557 Method of identifying a substance that affects long term memory and CREM/CREB/ATF-1 subfamily members
02/10/2004US6689369 Immunogenic pneumococcal protein and vaccine compositions thereof
02/10/2004US6689368 Synthetic immunogens; hcv core, e1, e2 and ns3 t cell determinants
02/10/2004US6689367 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
02/10/2004US6689366 Conformational epitope; characterization of human papillomavirus infection; vaccines
02/10/2004US6689365 Follicle stimulating hormone, luteinizing hormone; varying ratios of lh activity as compared to fsh activity; fsh beta is linked through a linker to lh beta; the alpha subunit is downstream from both; fusion protein
02/10/2004US6689364 Borrelia burgdorferi polypeptides and uses thereof
02/10/2004US6689363 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
02/10/2004US6689361 Peptide antigens antibodies specifically using antibody preparations raised in response to antigen(s) derived wholly or in part from proteins of the nematode caenorhabditis elegans.
02/10/2004US6689360 Antiproliferative agents
02/10/2004US6689359 Ligands, including antibodies, showing reactivity against endocrine cells
02/10/2004US6689356 Recombinant baculoviruses producing insect toxins
02/10/2004US6689354 Immunogenic preparation and method for improving the productivity of ruminant animals
02/10/2004US6689352 Polypeptide
02/10/2004CA2272854C Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives
02/10/2004CA2214247C Modulators of amyloid aggregation
02/10/2004CA2123430C Prohormone convertase transformed cells
02/09/2004CA2421269A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
02/05/2004WO2004011677A2 Viral marker
02/05/2004WO2004011676A2 Multi-reporter gene model for toxicological screening
02/05/2004WO2004011673A1 Auto-stimulating cells and method for making and using the same
02/05/2004WO2004011658A1 Expression receptors with 7 transmembrane domains in baculovirus- insect cell system
02/05/2004WO2004011651A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase
02/05/2004WO2004011650A2 Antigens encoded by alternative reading frame from pathogenic viruses
02/05/2004WO2004011649A1 Recombined myosin
02/05/2004WO2004011648A2 CYTOCHROME P450s
02/05/2004WO2004011640A1 Three-dimensional structure of dipeptidyl peptidase iv
02/05/2004WO2004011639A1 Novel cplap activating cpla2 enzyme in bovine brain, its use and the preparation method thereof
02/05/2004WO2004011636A2 Method of enzymatic deubiquitination
02/05/2004WO2004011620A2 Methods and compositions using polynucleotides and polypeptides of rank-associated inhibitor (rain)
02/05/2004WO2004011618A2 Methods of identifying adipocyte specific genes, the genes identified, and their uses
02/05/2004WO2004011617A2 Identification of a novel bitter taste receptor, t2r76
02/05/2004WO2004011615A2 USES OF CIRCADIAN GENE mPER2
02/05/2004WO2004011609A2 Methods for producing biological substances in pigment-deficient mutants of bacillus cells
02/05/2004WO2004011604A2 Nucleic acid-associated proteins
02/05/2004WO2004011601A2 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof
02/05/2004WO2004011599A2 Polypeptide cleavage process
02/05/2004WO2004011595A2 Vectors for transferring molecules of interest in target cells
02/05/2004WO2004011499A1 Novel albumins
02/05/2004WO2004011498A2 Long lasting natriuretic peptide derivatives
02/05/2004WO2004011497A1 Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap)
02/05/2004WO2004011496A2 Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
02/05/2004WO2004011495A1 Brca1-interacting protein
02/05/2004WO2004011493A1 The bzip type transcription factor of corn and its coding gene and the usage thereof
02/05/2004WO2004011492A1 Expression system
02/05/2004WO2004011490A1 A immounlogical epitope of the hiv strain type o and the uses thereof
02/05/2004WO2004011489A2 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells